Carol Gallagher - Frazier Healthcare
Frazier Healthcare - a life sciences investment firm who bought bought AndersonBrecon from AmerisourceBergen back in April - has added former CEO of Calistoga Pharmaceuticals Carol Gallagher to its team as a Venture Partner.
Gallagher began her career at Eli Lilly and has subsequently held senior positions at Biogen-Idec, Agouron Pharmaceuticals, CancerVax and Anadys Pharmaceuticals.
“We are thrilled to have Carol join our life science team,” said Jamie Topper, General Partner. “Her experience ranges from early stage drug development through successful commercialization strategies, and we are excited about leveraging those skills to continue our successes in life science investing.”